The European Commission finances European research and innovation projects, currently under the Horizon 2020 program, with the goal to ensure that international cooperation produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together to deliver innovation.
A robust European research consortium structure is the basis for the highly competitive pre-award phase, but also for the post-award phase, that lead to the expected impact.
Building your consortium is key and may involve stepping out of your comfort zone. genOway, as an experienced and qualified SME partner, can help you formulate a successful consortium.
genOway is a fully qualified SME partner validated by the European Commission.
We successfully participated in 13 EU programs, including one Horizon 2020 and six FP7 projects with an overall of 80 collaboration partners:
Qui animi soluta qui. Consectetur magni ut eaque ad vel minus quibusdam et. Dolorem non ut fugit provident ipsa officiis. Dolor autem consequuntur qui iure magni.
Eligendi qui ad ut et aliquid voluptatem. Amet sint quis ut culpa delectus sit quis. Hic expedita quo quisquam dolor amet pariatur nulla sint eum.
Physiological relevance
Comprehensive and reliable validation data
Over 600 scientific articles based on our models
In-depth expertise in preclinical science, physiology, and model development
Unique R&D platform located in France
Tailor-made approach to your needs
Strong emphasis on customer satisfaction
Long-standing partnerships with 17 of the top 20 pharma companies
Co-development of innovative models for next-generation drugs
Guaranteed FTO/freedom to operate